Publication Name	World Journal of Gastroenterology
Manuscript ID	18476
Country	Pakistan

Received	2015-04-21 15:36
Peer-Review Started	2015-04-22 18:57
To Make the First Decision	2015-06-25 10:12
Return for Revision	2015-06-25 20:55
Revised	2015-07-24 00:00
Second Decision	2015-10-12 16:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-10-20 09:13
Articles in Press	2015-10-20 09:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-13 15:21
Publish the Manuscript Online	2015-11-27 14:01

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Hepatitis B virus therapy: What’s the future holding for us?
Manuscript Source	Invited Manuscript
All Author List	Sobia Manzoor, Muhammad Saalim, Muhammad Imran, Saleha Resham and Javed Ashraf
Funding Agency and Grant Number
Corresponding Author	Sobia Manzoor, PhD, Assistant Professor, Atta-ur-Rahman School of Applied Bio-Sciences, Department of Healthcare Biotechnology, National University of Sciences and Technology, Islamabad 44000, Pakistan. lcianunique@yahoo.com
Key Words	hepatitis B virus treatment; hepatitis B virus vaccines; Immunomodulators; Non-nucleoside antivirals; Nucleoside analogues
Core Tip	The need to develop new therapeutic agents for hepatitis B virus treatment is the motivation factor for many research groups and pharmaceutical industries worldwide. The therapies in development from immunomodulation agents to non-nucleoside viral inhibitors hope to replace the current treatments with the promise of increased efficacy, minimum side effects and shorter duration of cure.
Publish Date	2015-11-27 14:01
Citation	Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: What’s the future holding for us? World J Gastroenterol 2015; 21(44): 12558-12575
URL	http://www.wjgnet.com/1007-9327/full/v21/i44/12558.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i44.12558

Full Article (PDF)	WJG-21-12558.pdf
Full Article (Word)	WJG-21-12558.doc
Manuscript File	18476-Review.doc
Answering Reviewers	18476-Answering reviewers.pdf
Audio Core Tip	18476-Audio core tip.mp3
Biostatistics Review Certificate	18476-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	18476-Conflict-of-interest statement.pdf
Copyright License Agreement	18476-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18476-Language certificate.pdf
Peer-review Report	18476-Peer-review(s).pdf
Scientific Misconduct Check	18476-Scientific misconduct check.pdf
Scientific Editor Work List	18476-Scientific editor work list.pdf